Hypertriglyceridemia in Patients with Type II Diabetes Mellitus

Authors

  • Muhammad Fahad Waseem
  • Ayaz Ahmed
  • Wajeeha Ahad
  • Naveed Aslam
  • Muhammad Arif Khan

Keywords:

Type II diabetes, Lipids, Triglycerides, Hypertriglyceridemia, Uncontrolled diabetes

Abstract

Objective:To determine the frequency of type II diabetic patients with hypertriglyceridemia.
Materials and Methods:This was a cross sectional study carried out at medical unit, PAF Hospital Mushaf, Sarghoda from
19th January 2013 to 18th July 2013. A total of 200 patients of either gender having age >30 years with type II diabetes either
controlled or uncontrolled for at least 5 years were enrolled in the study. Patients on anti-hyperlipidemic drug, with history of
ischemic heart disease, nephrotic syndrome, hypothyroidism and type I diabetes mellitus were excluded from the study.
Results: Mean (±SD) age of enrolled participants was 53.25 (±7.5) years. 86 (43%) were males and 114 (57%) were females.
Mean (±SD) fasting blood sugar level was 135 (±23.04) mg/dl and random blood sugar was 205.62 (±31.87) mg/dl. Mean
(±SD) duration of diabetes was 6.69 (±1.87) years. Out of 200 patients of type II diabetes, 102 (51%) had hypertriglyceridemia
out of which majority (63.7%) of patients had uncontrolled diabetes.
Conclusions:The frequency of type II diabetic patients with hypertriglyceridemia is found to be 51% with majority having
uncontrolled diabetes.

References

Nsiah K, Shang VO, Boateng KA, Mensah FO. Prevalence

of metabolic syndrome in type 2 diabetes mellitus

patients. International journal of applied & basic medical

research 2015;5(2):133-8.

Jisieike-Onuigbo NN, Unuigbe EI, Oguejiofor CO.

Dyslipidemias in type 2 diabetes mellitus patients in

Nnewi South-East Nigeria. Ann Afr Med 2011;10(4):285-

O'Brien T, Nguyen TT, Zimmerman BR, editors. Hyperlipidemia

and diabetes mellitus. Mayo Clinic Proceedings.

Elsevier; 1998.

Kumar and Clark. In: Kumar and Clark's Clinical Medicine.

Parveen Kum Michael CL,editor. Diabetes Mellitus

and Other Disorders of Metabolism, 7 ed: UK:ELSEVIER;

Wild S. Diabetes action now: an initiative of the World

Health Organization and the International Diabetes

Federation. Diabetes Care 2004:27:1047-53.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of

the prevalence of diabetes for 2010 and 2030. Diabetes

Res Clin Pract 2010;87(1):4-14.

Amos AF, McCarty DJ, Zimmet P. The rising global

burden of diabetes and its complications: estimates and

projections to the year 2010. Diabetic medicine: a journal

of the British Diabetic Association 1997;14Suppl 5(S5):

S1-85.

King H, Aubert RE, Herman WH. Global burden of diabetes,

–2025: prevalence, numerical estimates, and

projections. Diabetes care 1998;21(9):1414-31.

King H, Rewers M. Global estimates for prevalence of

diabetes mellitus and impaired glucose tolerance in

adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes

Care 1993;16(1):157-77.

Wild S, Roglic G, Green A, Sicree R, King H. Global

prevalence of diabetes estimates for the year 2000 and

projections for 2030. Diabetes care 2004;27(5):1047-

Zaidi SMH, Ghafoor A, Randhawa FA. HbA1c as an

indirect marker of hypertriglyceridemia in type 2 diabetes

mellitus. J Ayub Med Coll Abbottabad 2015;27(3):601-3

Siddiqui SA, Bano KA, Shabbir I, Bashir S, Hussain R.

Prevalence of dyslipidemia in Patients with type-2 diabetes

mellitus. Pak J Med Res 2011;50(1):29-33.

Temelkova-Kurktschiev T, Hanefeld M. The lipid triad

in type 2 diabetes - prevalence and relevance of hypertriglyceridemia/

low high-density lipoprotein syndrome

in type 2 diabetes. Experimental and clinical endocrinology

&diabetes: official journal, German Society of

Endocrinology and German Diabetes Association 2004;

(2):75-9.

Xu H, Song Y, You N-C, Zhang Z-F, Greenland S, Ford

ES, et al. Prevalence and clustering of metabolic risk

factors for type 2 diabetes among Chinese adults in

Shanghai, China. BMC Public Health. 2010;10(1):683

.DOI: 10.1186/1471-2458-10-683.

Bhatti SM, Dhakam S, Khan MA. Trends of lipid abnormalities

in Pakistani type-2 diabetes mellitus patients:

A tertiary care centre data. Pak J Med Sci 2009;25(6):883-

Haq A, Rehman J, Mahmood R, Safi A, Ahmed Z, Arif

S. Pattern of lipid profile in type-2 diabetes mellitus

patients. J Postgrad Med Inst 2006;20:366-9.

Jemima PG. Prevalence of hypertriglyceridemia among

newly detected type-2 diabetes in Coimbatore. IJSR

;4(8):2277-79.

Ludwig J, Sanbonmatsu L, Gennetian L, Adam E, Duncan

GJ, Katz LF, et al. Neighborhoods, obesity, and diabetes--

a randomized social experiment. The New England

journal of medicine 2011;365(16):1509-19.

Campos H, Genest JJ Jr. Blijlevens E, McNamara JR,

Jenner JL, Ordovas JM, et al. Low density lipoprotein

particle size and coronary artery disease. Arteriosclerosis

and thrombosis : a journal of vascular biology / American

Heart Association 1992;12(2):187-95.

Murphy HR, Steel SA, Roland JM, Morris D, Ball V,

Campbell PJ, et al. Obstetric and perinatal outcomes in

pregnancies complicated by Type 1 and Type 2 diabetes:

influences of glycemic control, obesity and social

disadvantage. Diabetic medicine : a journal of the British

Diabetic Association 2011;28(9):1060-7.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T,

Hemmingsen C, et al. Targeting intensive glycaemic

control versus targeting conventional glycaemic control

for type 2 diabetes mellitus. Cochrane Database Syst

Rev 2011;6(6):CD008143.

Giovannucci E, Harlan DM, Archer MC, Bergenstal

RM, Gapstur SM, Habel LA, et al. Diabetes and cancer:

a consensus report. Diabetes Care 2010;33(7):1674-85.

Kilpelainen TO, Zillikens MC, Stancakova A, Finucane

FM, Ried JS, Langenberg C et al. Genetic variation

near IRS1 associates with reduced adiposity and an

impaired metabolic profile. Nat Genet. 2011;43(8):753-60.

Webb D, Gray L, Khunti K, Srinivasan B, Taub N,

Campbell S, et al. Screening for diabetes using an oral

glucose tolerance test within a western multi-ethnic

population identifies modifiable cardiovascular risk: the

ADDITION-Leicester study. Diabetologia 2011;54(9):

-46.

Sperl-Hillen J, Beaton S, Fernandes O, Von Worley A,

Vazquez-Benitez G, Parker E, et al. Comparative effectiveness

of patient education methods for type 2 diabetes:

a randomized controlled trial. Arch Intern Med 2011;

(22):2001-10.

Downloads

Published

2016-09-14

How to Cite

Waseem, M. F. ., Ahmed, A. ., Ahad, W. ., Aslam, N. ., & Khan, M. A. . (2016). Hypertriglyceridemia in Patients with Type II Diabetes Mellitus. Journal of Bahria University Medical and Dental College, 6(3), 160–169. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/190

Issue

Section

Original Articles